(0.23%) 5 143.50 points
(0.11%) 38 485 points
(0.36%) 17 910 points
(-0.64%) $83.31
(1.82%) $1.958
(-0.16%) $2 343.40
(-0.11%) $27.51
(2.81%) $948.00
(-0.01%) $0.935
(-0.02%) $11.02
(-0.22%) $0.799
(1.88%) $93.60
-6.26% HKD 20.20
Live Chart Being Loaded With Signals
Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and medical devices and healthcare products in the People's Republic of China...
Stats | |
---|---|
Dzisiejszy wolumen | 18.07M |
Średni wolumen | 5.10M |
Kapitalizacja rynkowa | 63.00B |
EPS | HKD0 ( 2024-04-25 ) |
Last Dividend | HKD0.901 ( 2023-06-19 ) |
Next Dividend | HKD0 ( N/A ) |
P/E | 6.45 |
ATR14 | HKD0.0460 (0.23%) |
Wolumen Korelacja
SINOPHARM GROUP CO LTD Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
SINOPHARM GROUP CO LTD Korelacja - Waluta/Towar
SINOPHARM GROUP CO LTD Finanse
Annual | 2023 |
Przychody: | HKD596.57B |
Zysk brutto: | HKD48.51B (8.13 %) |
EPS: | HKD2.90 |
FY | 2023 |
Przychody: | HKD596.57B |
Zysk brutto: | HKD48.51B (8.13 %) |
EPS: | HKD2.90 |
FY | 2022 |
Przychody: | HKD552.15B |
Zysk brutto: | HKD47.43B (8.59 %) |
EPS: | HKD4.60 |
FY | 2021 |
Przychody: | HKD521.05B |
Zysk brutto: | HKD44.05B (8.45 %) |
EPS: | HKD2.49 |
Financial Reports:
No articles found.
SINOPHARM GROUP CO LTD Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0.901 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | HKD0.0101 | 2010-04-29 |
Last Dividend | HKD0.901 | 2023-06-19 |
Next Dividend | HKD0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 14 | -- |
Total Paid Out | HKD6.94 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2.6 | -- |
Div. Sustainability Score | 9.69 | |
Div.Growth Potential Score | 3.37 | |
Div. Directional Score | 6.53 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
6626.HK | Ex Dividend Knight | 2023-09-04 | Annually | 0 | 0.00% | |
1897.HK | Ex Dividend Knight | 2023-07-05 | Semi-Annually | 0 | 0.00% | |
0921.HK | Ex Dividend Junior | 2023-07-10 | Sporadic | 0 | 0.00% | |
0052.HK | Ex Dividend Knight | 2023-09-12 | Semi-Annually | 0 | 0.00% | |
2869.HK | Ex Dividend Junior | 2023-06-20 | Annually | 0 | 0.00% | |
1469.HK | Ex Dividend Knight | 2023-08-29 | Semi-Annually | 0 | 0.00% | |
0546.HK | Ex Dividend Knight | 2023-09-18 | Semi-Annually | 0 | 0.00% | |
8037.HK | No Dividend Player | 2023-05-19 | Sporadic | 0 | 0.00% | |
1997.HK | Ex Dividend Junior | 2023-08-25 | Semi-Annually | 0 | 0.00% | |
1070.HK | Ex Dividend Junior | 2023-07-18 | Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0155 | 1.500 | 9.69 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0358 | 1.200 | 8.81 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.194 | 1.500 | 8.96 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 1.395 | 0.800 | 8.03 | 6.42 | [1 - 3] |
quickRatioTTM | 1.034 | 0.800 | 8.63 | 6.90 | [0.8 - 2.5] |
cashRatioTTM | 0.264 | 1.500 | 9.64 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.188 | -1.500 | 6.87 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 20.69 | 1.000 | 3.45 | 3.45 | [3 - 30] |
operatingCashFlowPerShareTTM | 23.49 | 2.00 | 2.17 | 4.34 | [0 - 30] |
freeCashFlowPerShareTTM | 22.23 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.965 | -1.500 | 6.14 | -9.21 | [0 - 2.5] |
grossProfitMarginTTM | 0.0838 | 1.000 | -1.937 | -1.937 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0381 | 1.000 | -1.238 | -1.238 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 1.017 | 1.000 | 5.46 | 5.46 | [0.2 - 2] |
assetTurnoverTTM | 2.31 | 0.800 | 10.00 | 8.00 | [0.5 - 2] |
Total Score | 9.69 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 4.31 | 1.000 | 9.67 | 0 | [1 - 100] |
returnOnEquityTTM | 0.194 | 2.50 | 9.33 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 22.23 | 2.00 | 2.59 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 4.75 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 23.49 | 2.00 | 2.17 | 4.34 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0 | 1.500 | -3.33 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0825 | 1.000 | -0.437 | 0 | [0.1 - 0.5] |
Total Score | 3.37 |
SINOPHARM GROUP CO LTD
Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and medical devices and healthcare products in the People's Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail drug stores, and clinics. This segment also offers distribution, logistics, and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers, and other suppliers. The Medical Devices segment distributes medical devices. The Retail Pharmacy segment operates and franchises a network of retail drug stores. As of December 31, 2021, this segment had 10,259 retail pharmacies. The Other Business segment engages in the production and sale of pharmaceutical products, chemical reagents, and laboratory supplies. The company also rents and manages properties; distributes medical instruments, Chinese herbal medicines, antibiotics, and biological products; and offers information technology development and medicine consultation, investment, goods and technology import and export, business consultation, health consultation, medical consultation, market information consultation and investigation, and convention and exhibition services. In addition, it manages medical project investment, consulting, and technology training activities. Sinopharm Group Co. Ltd. has a strategic partnership with I-Mab to enhance its commercial capabilities and commercialization transformation. The company was founded in 2003 and is headquartered in Shanghai, the People's Republic of China. Sinopharm Group Co. Ltd. is a subsidiary of Sinopharm Industrial Investment Co., Ltd.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej